December 1, 2008Data supports Novartis malaria drug -US FDA staff - Guardian Unlimited Data supports Novartis malaria drug -US FDA staff - Guardian Unlimited
WASHINGTON, Dec 1 (Reuters) - Data show Novartis AG's combination malaria drug Coartem appears to work and causes few serious side effects, U.S. Food and Drug Administration regulatory staff said in documents released on Monday. The Swiss drugmaker Source: www.guardian.co.uk U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment - PR Inside www.allos.com/ - Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Source: www.pr-inside.com # posted by Network @ 3:00 PM
 |
Subscribe to Posts [Atom]